Found 9 matching trials
Open Registry Measuring Impact of Genomic Testing on Treatment Decision After Biopsy in Newly Diagnosed Prostate Cancer Patients
N/AThis registry is intended to measure the impact of Prolaris® testing on the...
Location
University of Washington
Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing
N/AMedicare is requesting outcome data on patients who received Prolaris testi...
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer
NAThis study seeks to determine the clinical impact of Gene Expression Classi...
Status
Active Not Recruiting
Location
University of Michigan Rogel Cancer Center
Prolaris Enhanced Risk Stratification - an ecONomic and clinicAL Evaluation
N/AOne in 8 men will be diagnosed with prostate cancer during their lifetime. ...
Location
St James's University Hospitals NHS Trust
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing
N/AThis registry will evaluate treatment selection for patients with newly dia...
Status
Active Not Recruiting
Location
Urology Centers of Alabama
Registry to Measure the Impact of Adding Genomic Testing
N/AThis is a prospective open registry to measure the impact on first-line the...
Location
Intermountain Healthcare
Prospective Prolaris Value and Efficacy
N/AThis is a prospective study to measure the impact on first-line therapy of ...
Location
VA San Diego Healthcare System
Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer
N/AThis is a long-term prospective registry study to determine whether Prolari...
Location
Urology Centers of Alabama
Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients
N/AThis registry is intended to evaluate the impact of genomic test results to...
Location
Multiple Locations